AAAAAA
Results:
1-16
|
Results: 16
Authors:
Newfield, RS
Spitz, IM
Isacson, C
New, MI
Citation: Rs. Newfield et al., Long-term mifepristone (RU486) therapy resulting in massive benign endometrial hyperplasia, CLIN ENDOCR, 54(3), 2001, pp. 399-404
Authors:
Maruo, T
Laoag-Fernandez, JB
Pakarinen, P
Murakoshi, H
Spitz, IM
Johansson, E
Citation: T. Maruo et al., Effects of the levonorgestrel-releasing intrauterine system on proliferation and apoptosis in the endometrium, HUM REPR, 16(10), 2001, pp. 2103-2108
Special issue - Progestins, progesterone receptor modulators, and progesterone antagonists - Preface
Authors:
Spitz, IM
Citation: Im. Spitz, Special issue - Progestins, progesterone receptor modulators, and progesterone antagonists - Preface, STEROIDS, 65(10-11), 2000, pp. 543-544
Authors:
Maruo, T
Matsuo, H
Samoto, T
Shimomura, Y
Kurachi, O
Gao, ZJ
Wang, Y
Spitz, IM
Johansson, E
Citation: T. Maruo et al., Effects of progesterone on uterine leiomyoma growth and apoptosis, STEROIDS, 65(10-11), 2000, pp. 585-592
Authors:
Spitz, IM
Chwalisz, K
Citation: Im. Spitz et K. Chwalisz, Progesterone receptor modulators and progesterone antagonists in women's health, STEROIDS, 65(10-11), 2000, pp. 807-815
Authors:
Spitz, IM
Van Look, PFA
Bennink, HJTC
Citation: Im. Spitz et al., The use of progesterone antagonists and progesterone receptor modulators in contraception, STEROIDS, 65(10-11), 2000, pp. 817-823
Authors:
Heikinheimo, O
Ranta, S
Grunberg, S
Spitz, IM
Citation: O. Heikinheimo et al., Alterations in sex steroids and gonadotropins in post-menopausal women subsequent to long-term mifepristone administration, STEROIDS, 65(10-11), 2000, pp. 831-836
Authors:
Spitz, IM
Bennink, HJTC
Citation: Im. Spitz et Hjtc. Bennink, Progesterone receptor modulators at the start of a new millennium, STEROIDS, 65(10-11), 2000, pp. 837-838
Authors:
Spitz, IM
Citation: Im. Spitz, The bible: truth or legend, fact or fantasy?, STEROIDS, 65(10-11), 2000, pp. 841-846
Authors:
Christin-Maitre, S
Bouchard, P
Spitz, IM
Citation: S. Christin-maitre et al., Drug therapy - Medical termination of pregnancy, N ENG J MED, 342(13), 2000, pp. 946-956
Authors:
Chertin, B
Spitz, IM
Lindenberg, T
Algur, N
Zer, T
Kuzma, P
Young, AJM
Catane, R
Farkas, A
Citation: B. Chertin et al., An implant releasing the gonadotropin hormone-releasing hormone agonist histrelin maintains medical castration for up to 30 months in metastatic prostate cancer, J UROL, 163(3), 2000, pp. 838-844
Authors:
Spitz, IM
Robbins, A
Citation: Im. Spitz et A. Robbins, Antiprogestins in clinical practice, PROGESTINS AND ANTIPROGESTINS IN CLINICAL PRACTICE, 2000, pp. 377-391
Authors:
Spitz, IM
Chertin, B
Lindenberg, T
Farkas, A
Citation: Im. Spitz et al., Long-acting gonadotropin-releasing hormone implant to maintain medical castration for two years in men with prostate cancer, N ENG J MED, 340(18), 1999, pp. 1439-1439
Authors:
Creinin, MD
Spitz, IM
Citation: Md. Creinin et Im. Spitz, Use of various ultrasonographic criteria to evaluate the efficacy of mifepristone and misoprostol for medical abortion, AM J OBST G, 181(6), 1999, pp. 1419-1424
Authors:
Maruo, T
Samoto, T
Yoshida, S
Matsuo, H
Nash, H
Spitz, IM
Johansson, E
Citation: T. Maruo et al., Estradiol/progesterone releasing vaginal rings for hormone replacement therapy in postmenopausal women, 9TH INTERNATIONAL MENOPAUSE SOCIETY WORLD CONGRESS ON THE MENOPAUSE, 1999, pp. 209-213
Authors:
Spitz, IM
Robbins, A
Citation: Im. Spitz et A. Robbins, Mechanism of action and clinical effects of antiprogestins on the non-pregnant uterus, HUM REP UPD, 4(5), 1998, pp. 584-593
Risultati:
1-16
|